InvestorsHub Logo

tractor4sale

03/18/24 1:23 PM

#63385 RE: A2Z #63384

Back in December 2022 when you got out the share price was not anywhere near .00083... That is where the share price is basically today…

johnnytrader33

03/18/24 1:42 PM

#63386 RE: A2Z #63384

Its pretty disgusting what the scum like Dixon, Ichim and add Veltmeyer to the list have done here. We all took massive losses (or have yet to take) as its just all lies and fraud. Its pure nuts!
Bearish
Bearish

johnnytrader33

03/18/24 1:43 PM

#63387 RE: A2Z #63384

remember Dixon pricing this pos company more than Amazon! HAHAAHHAHHAAAHAHA

strawpatch

03/18/24 2:48 PM

#63390 RE: A2Z #63384

The ultimate issue has been the cell line - the JadiCells.

As I see it, we first lost ~ 1 year, as there was the haggling over whether TSOI actually bought the rights to the cells or not.

Then we have lost another year, with the FDA requiring that the cells age a year.

It is what it is. I don't think it is anything wrong that TSOI did, but this is how business goes sometimes. I do still have hope that the aging of the cells is the last obstacle to beginning the ARDS trial.

In my head I give the trial a 50% chance to start - as $ still needs to be raised for the P3 trial. BUT, of all types of drugs, this is a relatively short horizon for a P3 study. For this indication, you know right away (within weeks) whether the "drug" did it's thing and was successful.